Hakim Nasrat A 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Dec 29, 2023
Insider Transaction Report
Form 4
Hakim Nasrat A
DirectorPresident & CEO
Transactions
- Award
Common Stock
2023-12-29$0.07/sh+2,223,147$153,397→ 2,223,147 total(indirect: Kristine Hakim)
Holdings
- 158,017,321
Common Stock
- 2,700,000(indirect: By IRA)
Common Stock
Footnotes (1)
- [F1]Shares issued in lieu of cash compensation for Pharmacovigilance and Medical Affairs consulting work during 2018-2022.